An analysis of data from the National Immunization Survey-Teen (NIS-TEEN) 2015 shows that parental concerns about human papillomavirus (HPV) vaccination are gender-specific.
An analysis of data from the National Immunization Survey-Teen (NIS-TEEN) 2015 shows that parental concerns about human papillomavirus (HPV) vaccination are gender-specific. Parents of girls are more likely to not vaccinate because of lack of sexual activity whereas parents of boys are less concerned about that or vaccine safety.
Presented at the 49th Annual SGO Annual Meeting, the findings from Poster 318 are by researchers from Johns Hopkins Hospital and School of Medicine and the National Cancer Institute. NIS-Teen provides national, regional, state, and selected local area estimates of vaccination coverage for vaccines recommended by the Advisory Committee on Immunization Practices.
Using provider-verified data from NIS-Teen, the authors calculated survey-weighted prevalence estimates of HPV vaccination initiation among boys and girls aged 13 to 17. They also calculated prevalence estimates for parent-reported reasons for lack of initiation and used survey-weighted X2 tests to compare reasons for lack of vaccination between parents of adolescent boys and girls.
In 2015, 63% of girls and 50% of boys had initiated HPV vaccination. For both genders, lack of necessity was the most common reasons for lack of vaccination (21% girls, 22% boys). For 13% of girls and 14% of boys, lack of knowledge about the vaccine was the most common reason for forgoing the shots (13% and 14%, respectively).
Parents of girls were more likely than parents of boys to cite lack of sexual activity as the reason their children were not vaccinated (15% vs 9%, P < 0.01). Parents of boys were significantly more likely than parents of girls to cite lack of a recommendation for vaccination from a provider as the reason they did not vaccinate their child (19% vs. 10%, P < 0.001). They also were less likely to be concerned about safety and side effects (9% vs 14%, P < 0.01).
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Identifying gaps in syphilis treatment and prenatal care among pregnant individuals
May 17th 2024Preventing congenital syphilis comes down to quick diagnosis and treatment of the infection in pregnancy, and the number of missed opportunities to do so in the United States continues to grow.
Read More